In silico cloning of the designed vaccine construct into an expression vector.

In silico cloning of the designed vaccine construct into an expression vector.

<p>In silico cloning of the CPXV-V5 vaccine into the pET28a (+) Escherichia coli expression vector.</p>

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Md. Mohaimenul Islam Tareq (21647527) (author)
مؤلفون آخرون: Sattyajit Biswas (21647530) (author), Farazi Abinash Rahman (21647533) (author), Labib Sharirar Siam (21647536) (author), Sadia Jannat Tauhida (21647539) (author), Shamim Ahmed (207438) (author), Hasan Jafre Shovon (21647542) (author), Mariya Ahmed (21647545) (author), Kazi Afrin Jerin (21647548) (author), Md. Nazmul Hasan (11525006) (author)
منشور في: 2025
الموضوعات:
Biochemistry
Medicine
Microbiology
Genetics
Biotechnology
Immunology
Cancer
Infectious Diseases
Virology
Biological Sciences not elsewhere classified
three outer membrane
term epitope visibility
structural validation enabled
quality 3d structures
lumpy skin disease
linked using aay
discover possible targets
certain distinctive features
proteins &# 8217
xlink "> cpxv
protein resolve a22
epitope vaccine constructions
namely sheeppox virus
developed vaccines might
computational cloning analysis
122 cpxv proteins
cell epitopes based
extracellular proteins
cell epitopes
scaffold protein
protein a35
v5 vaccine
potential vaccine
work used
vipr database
varied immunological
solid foundation
sheeppox ),
several investigations
results suggest
quite safe
practical settings
physiochemical properties
molecular weight
molecular modeling
molecular dynamics
l12 adjuvants
kk linkers
immunoinformatic methodology
huge socio
gtpv ),
grand average
generate multi
g activity
economic effects
docking scores
comprehensive immunity
cai value
amino acids
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة